More Hostile Biotec...
Health Care: Drugs
Amgen Inc. (AMGN: NASDAQ)
$52.91 0.40 | 0.76%
09/03/10 - 04:00 PM ET
5.36M / 6.29M
Vol / Avg. Vol:52.57 / 52.51
Open / Prev. Close:52.57 - 53.07
Today's Range:50.26 - 62.52
52 Wk Range:-6.47%
Performance YTD:TheStreet Rating:
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTheStreet Ratings Top-Rated...
- Contributor11 Famous Health Care Stock...
- ContributorHigh Volume Technicals for ...
- ContributorCramer's Wrong Hideout Stocks
- ContributorFast Money's Options Activi...
- Contributor10 Biotech Stocks on Clinic...
- ContributorFast Money's Big Week For P...
- ContributorFast Money's Anti-Volatilit...
- ContributorBarron's Companies That Sho...
- ContributorFast Money's Healthcare &am...
Latest AMGN Headlines from TheStreet
- 21 Drugs Facing FDA Approval Decisions 08.31.10 | 08:08 am
- 'Fast Money' Recap: Darkening Clouds 08.30.10 | 07:08 pm
- Gilead: Analysts' Upgrades, Downgrades 08.16.10 | 09:08 am
- Stocks Under $5: Two Finds
08.01.10 | 03:08 pm - Stock Wrap: The Real Story, July 30 07.30.10 | 04:07 pm
- Obama's Best Play, Biotech Stocks, Commodity Trading Tips 07.30.10 | 04:07 pm
- Amgen Q2 2010 Earnings Call Transcript 07.30.10 | 01:07 am
- Merck, Vale: Earnings Central 07.29.10 | 11:07 am
- Prescribing Medco 07.29.10 | 09:07 am
- Earnings Live Blog 07.29.10 | 07:07 am
Press Releases for AMGN
- Hospira Begins Phase I U.S. Clinical Trial Of Biosimilar Erythropoietin In Renal Patients - PR Newswire 07.26.10 | 10:07 am
- Amgen Donates $615,000 To Support International Medical Corps' Haiti Earthquake Disaster Relief Efforts - PR Newswire 01.26.10 | 03:01 pm
- Data Presented At San Antonio Breast Cancer Symposium Demonstrate Treatment With Denosumab Is Superior To The Standard Of Care - PR Newswire 12.10.09 | 01:12 pm
Partner Headlines for AMGN
- Big Pharma: Why In-Licensing Is Not the Cure - Seeking Alpha 08.29.10 | 07:08 am
- Cautious Outlook On Biotech Stocks (GILD, DNDN, AMGN, CELG, BIIB, GENZ) - Benzinga 08.16.10 | 01:08 pm
- UPDATE 1-Amgen's Vectibix fails head-and-neck cancer trial - Reuters 08.11.10 | 10:08 am
- Growth fears leave Wall Street flat - Financial Times 07.30.10 | 09:07 pm
- Company News for July 30, 2010 - Corporate Summary - Zacks 07.30.10 | 10:07 am
- Amgen Tops Zacks Consensus - Analyst Blog - Zacks 07.30.10 | 10:07 am
- UPDATE 1-US Medicare issues final dialysis payment rule - Reuters 07.26.10 | 05:07 pm
- Week in Preview: High Expectations for Southwest, Chevron, Broadcom - Daily Finance 07.25.10 | 05:07 pm
- Zacks Analyst Blog Highlights: Jinpan International, Whole Foods Market, Amgen, Novartis and GlaxoSmithKline - Press Releases - Zacks 07.20.10 | 08:07 am
- Monoclonal Antibody Companies Command Premiums - Seeking Alpha 07.12.10 | 08:07 am
